Kadın cinsel fonksiyon bozuklukları: 2018 güncelleme

Kadın cinsel disfonksiyonu (KCD); cinsel istek bozukluğu, orgazm, uyarılma ve cinsel ağrı gibi problemlerin birkaçını ya da tamamını bir arada bulunduran, psikoseksüel hastalıklar topluluğudur. Önceden beş tane olarak tanımlanan KCD, DSM-5’te sadeleştirilmiş ve üç ana başlık altında toplanmıştır. Kadın hipoaktif cinsel istek ve uyarılma disfonksiyonu, kadın cinsel ilgi/uyarılma bozukluğu olarak tek bir başlıkta birleştirilmiştir. Önceden ayrı olan disparoni ve vajinismus, genitopelvik ağrı / penetrasyon bozukluğu olarak adlandırılmıştır. Kadın orgazm bozukluğu bir kategori olarak kalmış ve değiştirilmemiştir. Şikâyetlerin erken dönemde saptanması, kadınların fiziksel, emosyonel, sağlığının korunmasını ve yaşam kalitesinin artmasını sağlayacaktır.

Female sexual function disorders: Updating 2018

Female sexual dysfunction (FSD); sexual dysfunction, orgasm, arousal, and sexual pain or a combination of all or some of the problems of psychosexual disorders. While KCD has been identified as five in the past, the DSM-5 has been simplified and grouped under three headings. Female hypoactive sexual desire and arousal dysfunction is combined into a single topic as female sexual arousal / arousal disorder. Previously separated dyspareunia and vaginismus are called genitopelvic pain/ penetration disorders. Female orgasmic disorder has remained a category and has not changed. Early detection of complaints will ensure the physical, emotional, and well-being of women and increase their quality of life.

PDF

___

Buster JE. Managing female sexual dysfunction. Fertil Steril 2013;100:905–15. [CrossRef]
Moreira ED, Glasser DB, Nicolosi A, Duarte FG, Gingell C; GSSAB Investigators’ Group. Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe. BJU Int 2008;101:1005–11. [CrossRef]
Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008;112:970–8. [CrossRef]
Hassanin IM, Helmy YA, Fathalla MM, Shahin AY. Prevalence and charactetistics of female sexual dysfunction in a sample of women from Upper Egypt. Int J Gynaecol Obstet 2010;108:219–23. [CrossRef]
Öksüz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol 2006;175:654–8. [CrossRef]
Ege E, Akın B, Yaralı Arslan S, Bilgili N. Sağlıklı kadınlarda cinsel fonksiyon bozukluğu ve risk faktörleri. TUBAV Bilim Dergisi 2010;3:137–44.
Akbulut MF, Üçpınar MB, Gürbüz ZG. Kadınlarda cinsel fonksiyon bozukluklarının sınıflaması ve tedavisi. Türkiye Klinikleri J Urology - Special Topics 2015;8:10–5.
Nappi RE, Cucinella L, Martella S, Rossi M, Tiranini L, Martini E. Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL). Maturitas 2016;94:87–91. [CrossRef]
Gomaa AA, Aziz NM, Thabet RH, Fouly HA, Altellawly SH, Gomaa GA. A pilot study of a topical intervention for treatment of female sexual dysfunction. J Clin Psychopharmacol 2018;38:60–7. [CrossRef]
Elnashar AM, İbrahim ME, El-Desoky MM, Ali OM, Hassan MESM. Female sexual dysfunction in lower Egypt. BJOG 2007;114:201–6. [CrossRef]
ISSWSH/NAMS Consensus Committee. ISSWSH position statement. J Sex Med 2014;11:1109. [CrossRef]
Latif EZ, Diamond MP. Arriving at the diagnosis of female sexual dysfunction. Fertil Steril 2013;100:898–904. [CrossRef]
Stephenson KR, Toorabally N, Lyons L, Meston C. Further validation of the Female Sexual Function Index: Specificity and associations with clinical interview Data. J Sex Marital Ther 2016;42:448–61. [CrossRef]
Krakowsky Y, Grober ED. A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada. Can Urol Assoc J 2018;12:211–6. [CrossRef]
Malmborg A, Persson E, Brynhildsen J, Hammar M. Hormonal contraception and sexual desire: A questionnaire-based study of young Swedish women. Eur J Contracept Reprod Health Care 2016;21:158–67. [CrossRef]
Cortelazzi D, Marconi A, Guazzi M, Cristina M, Zecchini B, Veronelli A, et al. Sexual dysfunction in pre-menopausal diabetic women: clinical, metabolic, psychological, cardiovascular, and neurophysiologic correlates. Acta Diabetol 2013;50:911–7. [CrossRef]
Pontiroli AE, Cortelazzi D, Morabito A. Female sexual dysfunction and diabetes: a systematic review and meta-analysis. J Sex Med 2013;10:1044–51. [CrossRef]
Dawson ML, Shah NM, Rinko RC, Veselis C, Whitmore KE. The evaluation and management of female sexual dysfunction. J Fam Pract 2017;66:722–8.
Höbek Akarsu R, Kızılkaya Beji N. Kadın cinsel fonksiyon bozuklukları sınıflandırılmasında DSM-V kapsamında yapılan değişiklikler. Androloji Bülteni 2016;18:134–7.
American Psychiatric Association. Sexual Dysfunctions. In: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: 2013. [CrossRef]
Rullo J, Faubion SS, Hartzell R, Goldstein S, Cohen D, Frohmader K, et al. Biopsychosocial Management of Female Sexual Dysfunction: A Pilot Study of Patient Perceptions From 2 Multi-Disciplinary Clinics. Sex Med 2018;6:217–23. [CrossRef]

ISSN: 2587-2524
Yayın Aralığı: Yılda 4 Sayı
Başlangıç: 1999
Yayıncı: Turgay Arık

Arşiv